NYSE:CIEN • US1717793095
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for CIENA CORP (CIEN).
| Date | Firm | Action | From → To |
|---|---|---|---|
| 2026-03-12 | TD Cowen | Initiate | Buy |
| 2026-03-06 | UBS | Maintains | Neutral -> Neutral |
| 2026-03-06 | Rosenblatt | Maintains | Buy -> Buy |
| 2026-03-06 | B. Riley Securities | Maintains | Neutral -> Neutral |
| 2026-03-06 | Stifel | Reiterate | Buy -> Buy |
| 2026-03-06 | Barclays | Maintains | Overweight -> Overweight |
| 2026-03-06 | B of A Securities | Upgrade | Neutral -> Buy |
| 2026-03-06 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-03-06 | Citigroup | Maintains | Buy -> Buy |
| 2026-03-05 | Needham | Maintains | Buy -> Buy |
| 2026-03-02 | JP Morgan | Maintains | Overweight -> Overweight |
| 2026-02-23 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2026-02-19 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2026-01-22 | Stifel | Maintains | Buy -> Buy |
| 2026-01-20 | B of A Securities | Downgrade | Buy -> Neutral |
| 2025-12-17 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-12 | Argus Research | Maintains | Buy -> Buy |
| 2025-12-12 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-12 | Rosenblatt | Maintains | Buy -> Buy |
| 2025-12-12 | Barclays | Maintains | Overweight -> Overweight |
| 2025-12-12 | JP Morgan | Maintains | Overweight -> Overweight |
| 2025-12-12 | B of A Securities | Maintains | Buy -> Buy |
| 2025-12-12 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-12-12 | Citigroup | Maintains | Buy -> Buy |
| 2025-12-11 | Needham | Maintains | Buy -> Buy |
| 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | ||
|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 4.387B 20.75% | 4.015B -8.47% | 4.77B 18.79% | 6.067B 27.20% | 7.06B 16.37% | 8.049B 14.01% | 8.639B 7.33% | 9.424B 9.09% | |
| EBITDA YoY % growth | 527.033M 32.62% | 324.679M -38.39% | 451.13M 38.95% | 1.154B 155.80% | 1.475B 27.82% | 1.805B 22.37% | 1.576B -12.69% | 1.747B 10.85% | |
| EBIT YoY % growth | 384.853M 49.63% | 191.209M -50.32% | 310.792M 62.54% | 1.015B 226.58% | 1.301B 28.18% | 1.521B 16.91% | N/A | N/A | |
| Operating Margin | 8.77% | 4.76% | 6.52% | 16.73% | 18.43% | 18.90% | N/A | N/A | |
| EPS YoY % growth | 2.72 40.93% | 1.82 -33.09% | 2.64 45.05% | 5.44 106.21% | 6.96 27.77% | 8.76 25.90% | N/A | N/A |
All data in USD
| Q2 / 26 | Q3 / 26 | Q4 / 26 | Q1 / 27 | Q2 / 27 | Q3 / 27 | Q4 / 27 | Q1 / 28 | Q2 / 28 | Q3 / 28 | Q4 / 28 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | 1.48 253.02% | 1.41 110.65% | 1.65 81.02% | 1.47 9.07% | 1.58 6.80% | 1.75 23.76% | 2.00 21.67% | 1.92 30.58% | 1.97 24.64% | 2.05 17.38% | 2.41 20.11% |
| Revenue Q2Q % growth | 1.532B 36.07% | 1.539B 26.21% | 1.647B 21.82% | 1.585B 11.07% | 1.656B 8.09% | 1.742B 13.19% | 1.882B 14.27% | 1.847B 16.53% | 1.883B 13.71% | 1.934B 11.02% | 2.132B 13.28% |
| EBITDA Q2Q % growth | 315.06M 208.53% | 301.95M 69.36% | 350.82M 35.54% | 328.72M 39.85% | 359.99M 14.26% | 392.04M 29.84% | 446.41M 27.25% | 383.97M 16.81% | 383.38M 6.50% | 381.06M -2.80% | 480.36M 7.61% |
| EBIT Q2Q % growth | 277.7M 698.22% | 271.42M 260.43% | 314.85M 165.72% | 299.61M 56.69% | 317.93M 14.49% | 350.06M 28.97% | 398.49M 26.57% | 361.62M 20.70% | 373.45M 17.46% | 388.45M 10.97% | 454.12M 13.96% |
All data in USD
24 analysts have analysed CIEN and the average price target is 261.07 USD. This implies a price decrease of -22.62% is expected in the next year compared to the current price of 337.38.
CIENA CORP (CIEN) will report earnings on 2026-06-03, before the market open.
The consensus EPS estimate for the next earnings of CIENA CORP (CIEN) is 1.48 USD and the consensus revenue estimate is 1.53B USD.
The consensus rating for CIENA CORP (CIEN) is 78.3333 / 100 . This indicates that analysts generally have a positive outlook on the stock.